V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003354 | 210012355 | 1.63 | 87.1 | Disease modification (D) | 2018-10-11 | 2019-01-18 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101398167 |
| 210003358 | 210012357 | 1.62 | 68.4 | Adjuvant (A) | null | 2017-01-31 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100534008 |
| 210003364 | 210012359 | null | 47.5 | Palliative (P) | null | 2017-09-14 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100922596 |
| 210003367 | 210012360 | null | 56.9 | null | null | 2019-09-30 | Paclitaxel 7 day | N | null | PACLITAXEL | 101819454 |
| 210003370 | 210012361 | 1.63 | 105 | Palliative (P) | 2019-12-16 | 2020-04-29 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100300042 |
| 210003372 | 210012362 | 1.61 | 54.5 | Adjuvant (A) | 2019-06-17 | 2019-06-29 | Docetaxel 100mg/m2 (21 day) | null | N | DOCETAXEL | 100784396 |
| 210003374 | 210012363 | 1.66 | 64 | Palliative (P) | 2019-03-20 | 2019-04-28 | CYCLOPHOSPHAMIDE + EPIRUBICIN | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100104750 |
| 210003376 | 210012364 | 1.61 | 61 | Neo-adjuvant (N) | 2020-08-09 | 2020-12-26 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101648428 |
| 210003380 | 210012365 | 1.59 | 103 | Palliative (P) | 2019-10-24 | 2019-10-26 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100381088 |
| 210003381 | 210012366 | 1.64 | null | Adjuvant (A) | null | 2019-03-15 | PACLITAXEL | N | null | PACLITAXEL | 101838247 |
| 210003383 | 210012367 | null | 73.7 | Adjuvant (A) | 2021-04-21 | 2021-05-06 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101405068 |
| 210003388 | 210012368 | 1.57 | 75.7 | Curative (C) | 2017-10-16 | 2017-10-23 | Trastuzumab | N | N | TRASTUZUMAB | 101361613 |
| 210003389 | 210012369 | null | null | Adjuvant (A) | null | 2017-08-10 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 100808778 |
| 210003392 | 210012370 | 1.72 | 55 | Palliative (P) | 2019-10-06 | 2019-10-21 | Trastuzumab Subcutaneous | N | N | TRASTUZUMAB | 100182714 |
| 210003400 | 210012373 | 1.69 | 104.4 | Adjuvant (A) | 2020-03-12 | 2020-03-12 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 101441451 |
| 210003403 | 210012374 | 1.61 | 103.6 | Adjuvant (A) | null | 2022-01-07 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100277269 |
| 210003407 | 210012376 | null | 72.6 | Neo-adjuvant (N) | 2021-10-20 | 2021-11-11 | EC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101465817 |
| 210003415 | 210012378 | 1.59 | null | null | null | 2018-01-22 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100289053 |
| 210003417 | 210012380 | 1.7 | null | Not known (9) | 2020-01-05 | 2020-05-18 | Docetaxel | 02 | N | DOCETAXEL | 100638452 |
| 210003421 | 210012382 | 1.75 | 85.8 | Adjuvant (A) | 2020-11-30 | 2021-03-09 | Docetaxel | 02 | N | DOCETAXEL | 101291223 |
| 210003422 | 210012383 | null | 122.9 | 03 | 2016-12-09 | 2016-12-31 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100481615 |
| 210003424 | 210012384 | null | null | Palliative (P) | 2020-01-12 | 2020-02-03 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100219252 |
| 210003425 | 210012385 | 1.65 | 93.5 | null | 2020-12-05 | 2021-02-02 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100143422 |
| 210003428 | 210012388 | 1.66 | 64.1 | Adjuvant (A) | 2020-10-22 | 2021-01-31 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100592120 |
| 210003429 | 210012389 | 1.56 | 87.9 | null | 2018-10-02 | 2018-12-30 | EC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100147183 |
| 210003431 | 210012390 | 1.62 | 95 | Adjuvant (A) | null | 2020-08-15 | Docetaxel | 02 | N | DOCETAXEL | 100614570 |
| 210003432 | 210012391 | 1.62 | 43.2 | Unknown (U) | 2021-09-02 | 2022-01-15 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101833996 |
| 210003434 | 210012393 | null | 64.2 | Palliative (P) | 2022-03-10 | 2022-03-16 | Paclitaxel (2 or 3 weekly) | null | N | PACLITAXEL | 100341751 |
| 210003435 | 210012394 | 1.63 | 55.4 | Adjuvant (A) | 2020-10-17 | 2020-11-16 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101535177 |
| 210003436 | 210012395 | null | 67.4 | null | 2019-06-06 | 2019-08-24 | TCH (21 day Trastuzumab) Maint | 02 | null | EC | 100136553 |
| 210003437 | 210012396 | null | null | null | null | 2019-05-03 | PERTUZUMAB + TRASTUZUMAB | 01 | null | PERTUZUMAB + TRASTUZUMAB | 100114068 |
| 210003440 | 210012398 | null | 77.8 | null | null | 2019-09-14 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101566652 |
| 210003442 | 210012399 | 1.66 | 69.8 | Palliative (P) | 2017-03-15 | 2017-07-27 | PERTUZUMAB + TRASTUZUMAB | null | null | PERTUZUMAB + TRASTUZUMAB | 101448039 |
| 210003443 | 210012400 | 1.66 | 44.7 | Neo-adjuvant (N) | 2018-09-14 | 2018-09-30 | Capecitabine | 02 | N | CAPECITABINE | 100181980 |
| 210003452 | 210012402 | 1.53 | 88 | Palliative (P) | 2019-08-23 | 2019-11-24 | Eribulin | 02 | N | ERIBULIN | 101775997 |
| 210003457 | 210012403 | null | 79.3 | null | 2016-05-13 | 2021-02-03 | ATEZOLIZUMAB + NAB PACLITAXEL | 02 | null | ATEZOLIZUMAB + NAB-PACLITAXEL | 100233095 |
| 210003460 | 210012404 | 1.65 | 48.9 | Adjuvant (A) | null | 2020-02-14 | Capecitabine | 02 | N | CAPECITABINE | 101755372 |
| 210003462 | 210012405 | 1.58 | 61.15 | Adjuvant (A) | 2017-09-10 | 2017-11-20 | Vinorelbine (oral) | null | N | VINORELBINE | 100074478 |
| 210003463 | 210012406 | 1.62 | 68.9 | Adjuvant (A) | 2021-11-04 | 2021-11-04 | Epirubicin (weekly) | 02 | N | ABEMACICLIB + FULVESTRANT | 100494571 |
| 210003467 | 210012408 | 1.54 | 82 | null | 2022-02-12 | 2022-02-13 | null | null | null | PALBOCICLIB | 101178524 |
| 210003468 | 210012409 | 1.67 | 61.2 | null | null | 2019-06-05 | null | 02 | null | ROSCO TRIAL | 100903040 |
| 210003469 | 210012410 | 1.62 | 114.4 | Adjuvant (A) | 2018-06-11 | 2018-08-13 | Carboplatin AUC 6 - 10 | null | N | CARBOPLATIN | 100346754 |
| 210003471 | 210012411 | 1.72 | 83.9 | Palliative (P) | null | 2018-08-04 | PERTUZUMAB + TRASTUZUMAB | null | N | PERTUZUMAB + TRASTUZUMAB | 100558104 |
| 210003472 | 210012412 | 0 | 70.9 | null | 2019-12-10 | 2019-12-10 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101457043 |
| 210003473 | 210012413 | 1.74 | 86.8 | null | 2017-06-23 | 2017-07-11 | TCH (21 day Trastuzumab) Maint | null | null | LETROZOLE + PALBOCICLIB | 100851270 |
| 210003474 | 210012414 | null | null | null | 2017-08-24 | 2022-02-08 | null | 02 | null | TRASTUZUMAB EMTANSINE | 101783446 |
| 210003483 | 210012415 | null | null | null | 2021-07-05 | 2021-09-15 | CAPECITABINE + PERTUZUMAB + TRASTUZUMAB | null | null | CAPECITABINE + CARBOPLATIN | 100054786 |
| 210003484 | 210012416 | null | 52.2 | null | 2018-02-21 | 2018-03-06 | VINORELBINE | null | null | FLUOROURACIL + OXALIPLATIN | 101074495 |
| 210003485 | 210012417 | 1.63 | null | Adjuvant (A) | 2019-05-04 | 2019-07-21 | Capecitabine | null | N | CAPECITABINE | 101283748 |
| 210003490 | 210012419 | 1.6 | 47.3 | Adjuvant (A) | 2020-04-16 | 2020-09-23 | Capecitabine | 02 | N | CAPECITABINE | 100177487 |